Largest Single-center Study Supports Hep C+ Heart Transplants
Leading EHR System Adopts Bundle to Prevent ICU Delirium
Vanderbilt experts guide Epic in integrating proven clinical protocol.
Photoreceptors: A New Pathway for Early DR Treatment?
Research explores retinal neuron dysfunction as a key stage in disease progression.
A New Suite of Diagnostic Tools for EGIDs
Research puts innovative focus on earlier, more tolerable interventions.
Improving Odds for ELGANs with Bronchopulmonary Dysplasia
PROP study aims to determine factors influencing long-term outcomes.
Upper Airway Lactobacillus to Reduce Risk of Wheezing Illness?
Bacteria could offer a biomarker and prevention strategy.
PERSONALIZED MEDICINE
Trials Add Support for Personalized PCa, RCC Treatment
New studies point to importance of individual patient factors.
Atlas Initiative to Map Colorectal Adenoma Progression
Moonshot project explores the microbiome for pathways from pre-polyp to malignancy.
New Milestones in Massive All of Us Collaborative
With Vanderbilt’s Josh Denny selected as new CEO, NIH’s groundbreaking initiative speeds into year two.
Applying AI to Longitudinal Data to Predict CVD
Research adds “time factor” to machine learning to track disease evolution.
Personalizing Treatment for Preterm Babies with PDA
Standard indomethacin regimen may fail in infants with CYP2C9*2 variant.
Patient Perceptions of Genomic Medicine
Common themes emerge from genomic medicine interventions.
Assessing Liquid Biopsies for Precision Cancer Care
Evaluating the potential to impact diagnosis and treatment.
Landmark GWAS Catalogs Blood Pressure Risk in 775,000+ Patients
Extensive catalog of genetic variants tied to BP opens doors to new therapies.